[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MY8400123A - Glucosamine derivatives and a process for their manufacture - Google Patents

Glucosamine derivatives and a process for their manufacture

Info

Publication number
MY8400123A
MY8400123A MY123/84A MY8400123A MY8400123A MY 8400123 A MY8400123 A MY 8400123A MY 123/84 A MY123/84 A MY 123/84A MY 8400123 A MY8400123 A MY 8400123A MY 8400123 A MY8400123 A MY 8400123A
Authority
MY
Malaysia
Prior art keywords
manufacture
glucosamine derivatives
glucosamine
derivatives
Prior art date
Application number
MY123/84A
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MY8400123A publication Critical patent/MY8400123A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MY123/84A 1975-12-10 1984-12-30 Glucosamine derivatives and a process for their manufacture MY8400123A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (1)

Publication Number Publication Date
MY8400123A true MY8400123A (en) 1984-12-31

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
MY123/84A MY8400123A (en) 1975-12-10 1984-12-30 Glucosamine derivatives and a process for their manufacture

Country Status (30)

Country Link
JP (1) JPS5273820A (en)
AR (2) AR224091A1 (en)
AT (1) AT365607B (en)
AU (1) AU508764B2 (en)
BE (1) BE849214A (en)
CA (1) CA1262400A (en)
CH (2) CH613709A5 (en)
CS (4) CS205027B2 (en)
DD (1) DD129781A5 (en)
DE (1) DE2655500A1 (en)
DK (1) DK154654C (en)
ES (2) ES454118A1 (en)
FI (1) FI64164C (en)
FR (1) FR2361902A1 (en)
GB (1) GB1570625A (en)
GR (1) GR61647B (en)
HK (1) HK32883A (en)
HU (1) HU177970B (en)
IE (1) IE44190B1 (en)
IL (1) IL51076A (en)
MY (1) MY8400123A (en)
NL (1) NL7613666A (en)
NO (1) NO144850C (en)
NZ (1) NZ182837A (en)
PL (4) PL110787B1 (en)
PT (1) PT65946B (en)
SE (1) SE445923B (en)
SG (1) SG11083G (en)
SU (3) SU660589A3 (en)
ZA (1) ZA767333B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH636887A5 (en) * 1976-04-26 1983-06-30 Syntex Inc Process for the preparation of novel immunological adjuvant compounds
EP0002677B1 (en) 1977-12-02 1982-10-13 Takeda Chemical Industries, Ltd. Glucosamine-peptide derivatives and their pharmaceutical compositions
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
EP0003833B2 (en) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigen derivatives, process for their preparation, pharmaceutical compositions containing them
FR2420545A1 (en) * 1978-03-20 1979-10-19 Anvar NEW ESTERS OF N-ACETYL-MURAMYL-AMINOACYL-GLUTAMIC ACID OR SUBSTITUTION DERIVATIVES THEREOF WITH ANTI-INFECTIOUS PROPERTIES AND / OR IMMUNOLOGICAL ADJUVANTS
FR2442241A2 (en) * 1978-03-20 1980-06-20 Anvar NOVEL ESTER COMPOUNDS OF MURAMYL-PEPTIDE, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, IN PARTICULAR IN THE FORM OF LIPOSOMES
FR2428051A1 (en) * 1978-06-05 1980-01-04 Anvar NOVEL MURAMYL-PEPTIDE COMPOUNDS AND MEDICAMENTS CONTAINING THEM
FR2428050A1 (en) * 1978-06-05 1980-01-04 Anvar OLIGOMERS OF MURAMYL-PEPTIDE COMPOUNDS AND DRUGS CONTAINING THEM
FR2446292A1 (en) * 1979-01-12 1980-08-08 Anvar MURAMYL-PEPTIDES FIXED ON PEPTIDE POLYMERS AND MEDICAMENTS CONTAINING THEM
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (en) 1979-02-20 1980-09-19 Anvar NOVEL MURAMYL-PEPTIDES SUBSTITUTED ON PEPTIDE NITROGEN AND MEDICAMENTS CONTAINING THEM
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (en) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogous procedure for the preparation of pharmacologically acting lipophilic a phosphatidylmuramyl peptides.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
EP0026746B1 (en) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
FI803077A (en) 1979-10-12 1981-04-13 Ciba Geigy Ag FOERFARANDE FOER FRAMSTAELLNING AV MYRAMYLPEPTIDER
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (en) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Active antibiotic compositions, process for their manufacture and process for the antibiotic activity of antibiotics
GR78246B (en) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (en) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka Muramyldipeptide active ester derivative
EP0541486A1 (en) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclic conjugates
US7838685B2 (en) 2005-04-27 2010-11-23 Shinji Takeoka Cationic amino acid type lipid
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10927147B2 (en) 2015-12-10 2021-02-23 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
US12134664B2 (en) 2015-12-10 2024-11-05 Bharat Biotech International Ltd. Muramyl peptide derivatives
US10576147B2 (en) * 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
US10717703B2 (en) 2017-08-21 2020-07-21 Celgene Corporation Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
ZA767333B (en) 1977-11-30
FR2361902A1 (en) 1978-03-17
CS205026B2 (en) 1981-04-30
IE44190B1 (en) 1981-09-09
SU747430A3 (en) 1980-07-23
DD129781A5 (en) 1978-02-08
ES454118A1 (en) 1978-03-01
FI64164B (en) 1983-06-30
NO144850C (en) 1981-11-25
AU508764B2 (en) 1980-04-03
AR220686A1 (en) 1980-11-28
DE2655500C2 (en) 1988-12-22
FR2361902B1 (en) 1980-11-07
DK154654C (en) 1989-05-08
AT365607B (en) 1982-02-10
ES465514A1 (en) 1978-09-16
PL110353B1 (en) 1980-07-31
NO764191L (en) 1977-06-13
CS205025B2 (en) 1981-04-30
PL194291A1 (en) 1978-10-23
SU1060118A3 (en) 1983-12-07
AU2042276A (en) 1978-06-15
CS205028B2 (en) 1981-04-30
DK154654B (en) 1988-12-05
BE849214A (en) 1977-06-09
PL110794B1 (en) 1980-07-31
HK32883A (en) 1983-09-02
FI64164C (en) 1983-10-10
AR224091A1 (en) 1981-10-30
IE44190L (en) 1977-06-10
SU660589A3 (en) 1979-04-30
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
CH613709A5 (en) 1979-10-15
PL110787B1 (en) 1980-07-31
JPS5273820A (en) 1977-06-21
IL51076A (en) 1980-09-16
IL51076A0 (en) 1977-02-28
NO144850B (en) 1981-08-17
NZ182837A (en) 1978-07-28
DE2655500A1 (en) 1977-06-23
SG11083G (en) 1983-09-16
HU177970B (en) 1982-02-28
SE445923B (en) 1986-07-28
PT65946A (en) 1977-01-01
CA1262400A (en) 1989-10-17
JPS638118B2 (en) 1988-02-19
DK552476A (en) 1977-06-11
PT65946B (en) 1978-06-14
FI763541A (en) 1977-06-11
CS205027B2 (en) 1981-04-30
ATA909276A (en) 1981-06-15
NL7613666A (en) 1977-06-14
PL112672B1 (en) 1980-10-31
SE7613851L (en) 1977-06-11
CH614718A5 (en) 1979-12-14

Similar Documents

Publication Publication Date Title
MY8400123A (en) Glucosamine derivatives and a process for their manufacture
ZA775652B (en) Fortimicin b derivatives and process for production thereof
HU172929B (en) Process for producing pyrido-pyrimido- or -thiasolo-quinasolone derivatives
GB1549047A (en) Prost-16-ynoic acid and derivatives and process for their manufacture
GB1550230A (en) Phenylindolines and process for their production
JPS5259134A (en) New aminoglycoside derivatives and process for manufacture thereof
IL49681A0 (en) New eburnamenine derivatives and a process for the preparation thereof
JPS524536A (en) 22hydroxybenzantron and process for producing substituted derivatives thereof
GB1549342A (en) 11-oxo-prostaglandin derivatives and processes for their manufacture
HU175266B (en) Process for producing dezacetyl 890a1 and dezacetyl 890a3
HU174587B (en) Process for producing thiasolidine derivatives
JPS51146438A (en) New cyclopropanol derivatives and process for manufacture thereof
ZA762785B (en) New benzo-diazepin derivatives and a process for their manufacture
IL50436A0 (en) Novel 4-hydroxymethyl-2-pyrrolidinone derivatives and their production
PT65617A (en) Antibiotic a-30912 and process for production thereof
GB1537901A (en) Aminocyclitol derivatives and a process for producing the same
ZA764162B (en) Fortimicin c and process for production thereof
GB1482879A (en) 5-benzyl-2-oxazolidone derivatives and a process for producing the same
ZA763135B (en) New prostane derivatives and process for their maunfactur
IL49716A0 (en) New thienyl-prostaglandins and process for their manufacture
KE2862A (en) A process for the manufacture of benodiazepine derivatives
GB1554950A (en) D - homo - 20 - keto -steroids and process for their manufacture
GR63597B (en) Fortimicin b derivatives and process for production thereof
JPS5223074A (en) Hexahydroo2hhindazole derivatives and production thereof
HU173109B (en) Process for producing imidazolobenzodiazepine derivatives